Comparison
Hims vs Mochi Health
Independent, side-by-side. Same methodology, same sourcing standard, no payment accepted from either. Prices are observed market pricing (snapshot 2026-07-20); receipts are computed from sourced records.
| Hims | Mochi Health | |
|---|---|---|
| Verdict | Profile in progress | Profile in progress |
| Tirzepatide price | Not tracked | from $278/mo (monthly plan) |
| Semaglutide price | from $199/mo (12-mo prepay) | from $165/mo (3-mo prepay) |
| Pharmacy receipt | Names its pharmacy (Strive Pharmacy, Curexa +1) — Strive Pharmacy, RedRock Pharmacy state-verified by us in up to 17 states. Pick your state to check yours. | Fills through DCA Pharmacy, Empower +2 per market data — Empower is an FDA-registered 503B outsourcing facility (federal cGMP oversight). Pick your state to check the rest. |
| Care receipt | Care is outsourced to You Health — a contract medical group named on the clinic's own site. The brand doesn't employ your clinician. | Outsourced contract clinicians — the brand doesn't employ your clinician — with check-ins and coaching on record. |
| Review integrity | Review-integrity flag — 72% of its Trustpilot reviews are unprompted "organic" posts, past our 40% gaming threshold. | Clean review record — 5% unprompted on 4,934 reviews, within our 40% threshold. |
| Company address | Its listed address is a registered-agent or mailbox service — no operating location stands behind the brand's listed address. | Lists a real-looking operating address on its own site. |
| Pharmacy | In review | In review |
| Clinical support | In review | In review |
| Patient support | In review | In review |
| Value | In review | In review |
| Ships to | In review | 50 states |
| Pharmacy model | Hims is unusually vertically integrated for a GLP-1 telehealth brand: Hims & Hers Health, Inc. owns and operates its own pharmacy and manufacturing chain rather than only contracting out. Per its FY2025 Form 10-K, the company operates two licensed 503A mail-order pharmacies that fill solely for its own customers - Apostrophe Pharmacy LLC and XeCare, LLC, both now wholly-owned subsidiaries - plus a licensed 503B outsourcing facility, MedisourceRx (acquired September 2024 as Seaview Enterprises, LLC, for $31.0 million; Los Alamitos, CA), which compounded its injectable semaglutide, and a peptide manufacturing facility. The consumer Terms also name third-party partner pharmacies (EHT Pharmacy LLC dba Curexa, CD Pharmacy LLC dba Red Rock Pharmacy, AnazaoHealth Corporation, and Strive Specialties, Inc.). During the April-June 2025 Novo Nordisk bundle, brand-name Wegovy was dispensed through Novo's own NovoCare Pharmacy accessed via the Hims platform. Prescriptions are written by providers in affiliated 'You Health' professional medical groups; Hims & Hers states in its Terms that it is not itself a healthcare provider. | Marketplace model: Mochi routes prescriptions to a network of compounding pharmacies and says patients pick a partner pharmacy in the patient portal. Mochi does not publish a full list of its partner pharmacies. One reported affiliated pharmacy, Aequita Pharmacy of Kirkland, WA, was subject to a Washington State Limited Stop Service in March 2025 and reportedly closed in April 2025. |
| Red flags on file | 5 | 3 |
Visit hims.com
Plain link, not sponsored — we take no payment for this.
Full profiles: Hims → · Mochi Health →
State-aware license reads: the tirzepatide price board →